Abstract:Abstract:ObjectiveTo analyze the methylation status of DcR1, DcR2, DR4, DR5 gene promoters in jugular paraganglioma and to study their clinical significance.MethodsMethylationspecific PCR (MSP) was used to analyze the methylation of the 4 promoters in 12 jugular paragangliomaspecimens. Great auricular nerve specimens obtained from patients suffering from benign tumor of parotid gland were chosen as control.ResultsAll the four genes showed methylation of promoters in jugular paraganglioma with respective methylation rates of 36.4%, 41.7%, 75.0% and 33.3%. Nomethylation of promoters could be detected in the normal nerves. Patients with high methylation index (MI>0.05) were younger at diagnosis than those with low methylation index(MI≤0.05,P=0.0189).ConclusionsMethylation of DcR1,DcR2,DR4 and DR5 promoters exists in jugular paragangliomas and maybe associated with the genesis and development of this tumor. Due to its reversibility, methylationis a potential targetin furthertargeted therapy of tumor.